RPS joins UK Health Alliance on Climate Change
We've joined the UK Health Alliance on Climate Change (UKHACC).
The Alliance brings together a number of organisations including many Royal Colleges, Faculties of Health, the British Medical Jour (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 23, 2022 Category: Drugs & Pharmacology Source Type: news
Post-registration foundation pharmacist programme
Health Education and Improvement Wales (HEIW) and Cardiff University will be offering a post-registration foundation pharmacist programme to newly registered pharmacists in Wales, which will use the n (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 22, 2022 Category: Drugs & Pharmacology Source Type: news
Recall of two infant formula powders
Food Standards Agency (FSA) has issued a recall in relation to batches of Elecare Similac and Alimentum Similac infant formula powders. This product is classified as a food substance, however the Medi (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 22, 2022 Category: Drugs & Pharmacology Source Type: news
RPS England Chair talks about restrictions easing on BBC News
The Government announced that the easing of COVID restrictions in England would be brought forward from the original date of March 24.
This would include no longer having to legally self-isolate.
RP (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 21, 2022 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines Recall: medac GmbH (Fluorouracil Injection)
medac GmbH (t/a medac Pharma LLP) are recalling certain product batches as a precautionary measure due to visual detection of glass lamellae particles during an ongoing stability study.
Further infor (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 17, 2022 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines Recall: Uni Health Distribution, Efudix cream
Uni Health Distribution is aware of a potential issue where the leaflet contained within Efudix 5% w/w cream (2 x 20g) pack, batch 80193439/B may be incorrect.
Further information and actions for hea (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 17, 2022 Category: Drugs & Pharmacology Source Type: news
Class 2 Medicines Recall: hameln pharma ltd, Water for Injections BP – 100ml vial
hameln pharma ltd is recalling a batch of a product as a precautionary measure as remaining vials may no longer be in line with the licensed product specification
Further information and actions for (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 17, 2022 Category: Drugs & Pharmacology Source Type: news
Recognising LGBTQIA+ microaggressions
We’ve launched a guide to LGBTQIA+ related microaggressionsas part of our Inclusion and Diversity workstream. It joins others in the series, which examine race, disability and gender microaggres (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 16, 2022 Category: Drugs & Pharmacology Source Type: news
Response to NHS Race and Health Observatory review
We've responded to a major review into ethnic inequalities in healthcare.
Commenting on the recent report from the NHS Race and Health Observatory into ethnic inequalities across healthcare, RPS (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 15, 2022 Category: Drugs & Pharmacology Source Type: news
Parliamentary Motion: Pharmacy 2030
A Parliamentary Motion has been lodged in the Scottish Parliament to celebrate the publication of Pharmacy 2030, Royal Pharmaceutical Society (RPS) Scotland’s brand new professional vision for t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 15, 2022 Category: Drugs & Pharmacology Source Type: news
RPS responds to delivery plan for tackling COVID-19 backlog
We've responded to the NHS England delivery plan for tackling the COVID-19 backlog of elective care, published this week.
Thorrun Govind, Chair of RPS England, commented on the plan:“Pharma (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 9, 2022 Category: Drugs & Pharmacology Source Type: news
Professional responsibility to reduce risk of COVID-19 infection to patients.
The Chief Medical Officer, Chief Pharmaceutical Officer and others have issued a letter regarding COVID-19 vaccination. The letter can be accessed here. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 7, 2022 Category: Drugs & Pharmacology Source Type: news
RPS congratulates Queen on her Platinum Jubilee
We've written a letter to our Patron, Her Majesty The Queen, congratulating her on her Platinum Jubilee.
The Platinum Jubilee marks 70 years since the accession of Queen Elizabeth II on 6 Februar (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 6, 2022 Category: Drugs & Pharmacology Source Type: news
RPS welcomes new PSNC CEO
RPS England has welcomed the appointment of Janet Morrison OBE as the new CEO of PSNC.
Janet has previously led Independent Age and was the founder and Chair of the Campaign to End Loneliness
She wi (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 4, 2022 Category: Drugs & Pharmacology Source Type: news
RPS responds to news HRT could be available at pharmacies
The MHRA has launched a public consultation on a set of proposals to make Gina 10 mg tabletsavailable from pharmacies. HRT could be made available at pharmacies.
Thorrun Govind, Chair of RPS in Engla (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 3, 2022 Category: Drugs & Pharmacology Source Type: news
